U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

i

Fibrosis and Steatotic Liver Disease in US Adolescents According to the New Nomenclature



Details

  • Personal Author:
  • Description:
    Objective: To apply the new nomenclature for steatotic liver diseases (SLD), replacing nonalcoholic fatty liver disease (NAFLD) with metabolic dysfunction-associated steatotic liver disease (MASLD), in adolescents using National Health and Nutrition Examination Survey (NHANES) data. Methods: Among 1410 adolescents (12-19 years) in NHANES (2017-March, 2020), the controlled attenuation parameter (CAP) of transient elastography (TE) was used to define steatosis and fibrosis (TE ≥ 7.4 kPa). Obesity and alanine aminotransferase (ALT) ≥ 80 U/L were used to identify adolescents qualifying for hepatology referral according to practice guidelines. NAFLD was defined as liver steatosis without a specific exposure; it has no cardiometabolic risk factor requirement, unlike MASLD. Results: Steatosis (yes/no) is the first decision point in the new diagnostic protocol; however, criteria for steatosis are undefined. At the supplier (EchoSens)-recommended CAP threshold of 240 dB/m, 30.5% (95% confidence interval [CI]: 27.1%-34.0%) of adolescents had SLD and about 85% of adolescents with NAFLD met criteria for MASLD. The other 15% would receive an ambiguous diagnosis of either cryptogenic SLD or possible MASLD. At higher CAP thresholds, MASLD/NAFLD concordance increased and approached 100%. Among adolescents with MASLD-fibrosis, only 8.8% (95% CI: 0%-19.3%) had overweight/obese and ALT ≥ 80 U/L. Conclusions: The new nomenclature highlights the high prevalence of liver steatosis. At the CAP threshold of 240 dB/m, however, approximately 15% of adolescents would receive an ambiguous diagnosis, which could lead to confusion and worry. Fewer than 10% of adolescents with MASLD-fibrosis had overweight/obese and ALT ≥ 80 U/L. Revised guidelines are needed to ensure that the other 90% receive appropriate referral and liver disease care. [Description provided by NIOSH]
  • Subjects:
  • Keywords:
  • ISSN:
    0277-2116
  • Document Type:
  • Funding:
  • Genre:
  • Place as Subject:
  • CIO:
  • Topic:
  • Location:
  • Pages in Document:
    229-237
  • Volume:
    79
  • Issue:
    2
  • NIOSHTIC Number:
    nn:20069663
  • Citation:
    J Pediatr Gastroenterol Nutr 2024 Aug; 79(2):229-237
  • Contact Point Address:
    Andrea D. Branch, Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Pl, Box 1123, New York, NY 10029, USA
  • Email:
    andrea.branch@mssm.edu
  • Federal Fiscal Year:
    2024
  • Performing Organization:
    Icahn School of Medicine at Mount Sinai, New York
  • Peer Reviewed:
    True
  • Start Date:
    20170701
  • Source Full Name:
    Journal of Pediatric Gastroenterology and Nutrition
  • End Date:
    20240630
  • Collection(s):
  • Main Document Checksum:
    urn:sha-512:f9867b252dec9cadc6934fe0f953d6a6cad016101f6a6989cc5ea7d35cdfcbd2efb1b3065a3340cfbc9996cfffa18c4816a8ddbb3162fb021f47f5cf83c0c953
  • Download URL:
  • File Type:
    Filetype[PDF - 1.21 MB ]
ON THIS PAGE

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.